Search

‘There has been a 73 per cent reduction in children hospitalised from severe chicken pox infection since the introduction of the (varicella) vaccine to the National Immunisation Program in Australia in 2005.'1

Associate Professor Leah Cosgrove and her team have developed a simple blood test to diagnose colorectal cancer. A reliable, non-invasive blood test could augment the National Bowel Cancer Screening Program, either as an adjunct primary screen for those unable to do the stool test, or in triaging positive subjects to colonoscopy. This could help drive a significant reduction in colorectal cancer deaths in Australia.

‘18 per cent of all Indigenous Australian adults have chronic kidney disease—two times as likely as non-Indigenous Australians.’

Through accreditation, the Research Translation Centres are recognised for their leadership and excellence in research, translation, collaboration, and the training of health professionals and other end-users in an evidence-based environment.

The ME/CFS Scoping Survey was released by NHMRC on 21 February 2025 and was open for 9 weeks through to 27 April 2025. The survey was open to the public and was designed to gather insights from individuals with ME/CFS and related conditions (Long COVID, postural orthostatic intolerance syndrome (POTS) and fibromyalgia), carers, GPs and other healthcare professionals that provide care to people with ME/CFS and related conditions, researchers and consumer organisations. The purpose of the survey was to understand what stakeholders consider priorities for inclusion in the new Australian ME/CFS Clinical Practice Guidelines and to understand patient and healthcare professionals’ experiences of barriers to and/or enablers of care.The full report is available from the Downloads section.